Treatment of critical limb ischemia and diabetic foot disease by the use of autologous stem cells;Terapie kritické končetinové ischemie u pacientů se syndromem diabetické nohy pomocí autologních kmenových buněk

Vnitrni Lekarstvi

Volumn 57, Issue 5, 2011, Pages 451-455

  Dubský, Michal ^a   Jirkovska A ^a   Bem R ^a   Pagacova L ^a   Fejfarova V ^a   Varga, M ^a   Skibova J ^a   Langkramer, S ^b   Syková, Eva ^b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b Pracoviště Laboratorních Metod IKEM Praha ^*  (Czech Republic)

Author keywords

Diabetic foot; Peripheral arterial disease; Revascularization; Stem cells

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANALGESIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW CELL; CELL SUSPENSION; CLINICAL ARTICLE; CRITICAL LIMB ISCHEMIA; DIABETIC FOOT; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOSTIMULATION; LIMB ISCHEMIA; LIMB PAIN; MALE; PERIPHERAL BLOOD STEM CELL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REST; SAFETY; STROMA CELL; THERAPY EFFECT; TRANSCUTANEOUS OXYGEN MONITORING; VISUAL ANALOG SCALE; WOUND HEALING; AGED; DIABETES MELLITUS; ISCHEMIA; LEG; METHODOLOGY; MIDDLE AGED; PAIN ASSESSMENT; STEM CELL TRANSPLANTATION; VASCULARIZATION;

AGED; BLOOD GAS MONITORING, TRANSCUTANEOUS; DIABETES COMPLICATIONS; DIABETIC FOOT; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; PAIN MEASUREMENT; STEM CELL TRANSPLANTATION;

EID: 79958863783     PISSN: 0042773X     EISSN: 18017592     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Jirkovská A. Ischemická choroba dolních končetin u pacientů s diabetem: Konzervativní terapie. In: Jirkovská A (ed.). Syndrom diabetické nohy. Praha: Maxdorf 2006; 161-165.
2. Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease: Meta-analysis and systematic review of the literature. Atherosclerosis 2010; 209: 10-17.
3. Awad O, Dedkov EI, Jiao C et al. Differential healing activities of CD34+ and CD14+ endothelial cell progenitors. Arterioscler Thromb Vasc Biol 2006; 26: 758-764. (Pubitemid 43732148)
4. Timmermans F, Van Hauwermeiren F, De Smedt M et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007; 27: 1572-1579. (Pubitemid 46986112)
5. Matoba S, Matsubara H. Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for peripheral artery diseases by autologous bone marrow cell transplantation. Curr Pharm Des 2009; 15: 2769-2777.
6. Tateishi-Yuayama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet 2002; 360: 427-435.
7. Huang P, Li S, Han M et al. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005; 28: 2155-2160. (Pubitemid 41242461)
8. Al Mheid I, Quyyumi AA. Cell therapy in peripheral arterial disease. Angiology 2009; 59: 705-716.
9. Attanasio S, Snell J. Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review. Cardiol Rev 2009; 17: 115-120.
10. Wahlberg E. Angiogenesis and arteriogenesis in limb ischemia. J Vasc Surg 2003; 38: 198-203. (Pubitemid 41123313)
11. Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004; 20: S90-S95. (Pubitemid 38714342)
12. Gough A, Clapperton M, Rolando N et al. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet 1997; 350: 855-859. (Pubitemid 27404347)
13. Procházka V, Gumulec J, Chmelová J et al. Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot. Vnitř Lék 2009; 55: 173-178.
14. Dubský M, Jirkovská A, Bém R et al. Možnosti buněčné terapie v léčbě ischemické choroby dolních končetin u syndromu diabetické nohy. DMEV 2009; 12: 128-132.
15. Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost 2010; 103: 696-709.